Filtered By:
Condition: Heart Failure
Education: Study
Procedure: Angioplasty
This page shows you your search results in order of relevance. This is page number 20.
Order by Relevance | Date
Total 448 results found since Jan 2013.
Increased Risk of Adverse Cardiovascular Events by Strict Glycemic Control after Percutaneous Coronary Intervention (HbA1c & lt; 6.5% at 2 Years) in Type 2 Diabetes Mellitus Combined with Acute Coronary Syndrome: a 5-years follow-up study
Conclusions: The findings indicated an increased risk of MACEs by strict glycemic control after PCI (2-year HbA1c < 6.5% after PCI) in type 2 diabetes mellitus combined with ACS who underwent PCI.PMID:34166166 | DOI:10.1080/03007995.2021.1947219
Source: Current Medical Research and Opinion - June 24, 2021 Category: Research Authors: Tiangui Yang Peng Fu Jie Chen Xi Fu Changlu Xu Xiaoxia Liu Tiesheng Niu Source Type: research
Safety of Early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention: a nationwide cohort study
CONCLUSIONS: Nationwide observational data suggests that early discharge of low-risk patients with STEMI treated with PCI is not associated with an increase in 1-year MACE.PMID:34338642 | DOI:10.4244/EIJ-D-21-00501
Source: EuroIntervention - August 2, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Troels Yndigegn Patrick Gilje Josef Dankiewicz Arash Mokhtari Nazim Isma Jasminka Holmqvist Alexandru Schiopu Annika Ravn-Fischer Robin Hofmann Karolina Szummer Tomas Jernberg Stefan K James Chris P Gale Ole Fr öbert Moman A Mohammad Source Type: research
CHA2 DS2 -VASc score as a predictor for contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention
ConclusionCHA2DS2-VASc score is a simple risk score for bedside, preprocedure CIN risk stratification among ACS patients who underwent primary PCI.
Source: QJM - October 1, 2021 Category: Internal Medicine Source Type: research
Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study
ConclusionPrior CEVD was associated with a significantly increased risk of 10 year all-cause death which was similar in patients treated with PCI or CABG. These results do not support preferential referral for PCI rather than CABG in patients with prior CEVD.Trial registration: SYNTAX: ClinicalTrials.gov reference: NCT00114972. SYNTAX Extended Survival: ClinicalTrials.gov reference: NCT03417050.Graphic abstract
Source: Clinical Research in Cardiology - October 1, 2021 Category: Cardiology Source Type: research
Simplified Academic Research Consortium for High Bleeding Risk (ARC-HBR) Definition Predicts Bleeding Events in Patients With Heart Failure
CONCLUSIONS: The simplified ARC-HBR definition predicts a high risk of bleeding events in patients with HF.PMID:34707066 | DOI:10.1253/circj.CJ-21-0686
Source: Circulation Journal - October 28, 2021 Category: Cardiology Authors: Yu Sato Akiomi Yoshihisa Ryohei Takeishi Himika Ohara Yukiko Sugawara Yasuhiro Ichijo Yu Hotsuki Koichiro Watanabe Satoshi Abe Tomofumi Misaka Takamasa Sato Masayoshi Oikawa Atsushi Kobayashi Kazuhiko Nakazato Yasuchika Takeishi Source Type: research
The Impact of Urate-Lowering Therapy in Post-Myocardial Infarction Patients: Insights from a Population-Based, Propensity Score-Matched Analysis
Clin Pharmacol Ther. 2021 Oct 31. doi: 10.1002/cpt.2473. Online ahead of print.ABSTRACTThe role of urate-lowering therapy (ULT) for the primary prevention of cardiovascular events has been widely discussed, but its evidence for the secondary prevention of myocardial infarction (MI) is limited. Therefore, we conduct a population-based, propensity score-matched cohort study to investigate the cardiovascular outcomes among post-MI patients with and without ULT. A total of 19,042 newly diagnosed in-hospital MI patients were selected using the Taiwan National Health Insurance Database between 1 January 2005 and 31 December 2016...
Source: Clinical Pharmacology and Therapeutics - October 31, 2021 Category: Drugs & Pharmacology Authors: Chi-Jung Tai Chin-Chung Wu Kun-Tai Lee Tzyy-Guey Tseng Hui-Chun Wang Fang-Rong Chang Yi-Hsin Yang Source Type: research
